Jupiter Life Line Hospitals Ltd. (JLHL) AI Stock Analysis

• Market Cap: ₹88.23B
• Dividend Yield: 0.14%
• Average Volume (3M): 947.00
• Price to Earnings (P/E): 46.8
• Beta (1Y): 0.31
• Revenue Growth: 18.40%
• EPS Growth: 7.30%
• Country: IN
• Employees: 4,586
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 7.00
• Shares Outstanding: 65,566,025
• 10 Day Avg. Volume: 721
• 30 Day Avg. Volume: 947
• PEG Ratio: 14.64
• Price to Book (P/B): 7.55
• Price to Sales (P/S): 8.12
• P/FCF Ratio: -151.89
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 67 Neutral
• Price Target: ₹1,363.00 ▼(-11.64% Downside)

Jupiter Life Line Hospitals Ltd. has a strong financial foundation with consistent revenue and profit growth, which is the most significant factor. Technical analysis indicates a stable upward trend, but the high P/E ratio suggests overvaluation, impacting the overall score.

Positive Factors

Consistent revenue and profit growth

Sustained revenue and profit expansion indicates enduring demand for the company’s tertiary/quaternary hospital services. This trend supports capacity investments, improves ability to service debt, and provides a durable platform for network growth and margin preservation over the medium term.

Improving margins and operational efficiency

Rising gross and net margins and strong EBIT/EBITDA reflect better cost management and operational leverage. Higher per-case profitability enhances cash generation potential and resilience to pricing pressure, supporting sustainable earnings power and reinvestment capacity over the next several quarters.

Healthy balance sheet and manageable leverage

A balanced leverage profile and robust ROE provide financial flexibility for capex, acquisitions, or expansion of clinical services without excessive refinancing risk. Stability in the equity ratio supports long-term funding of hospital infrastructure and strategic growth initiatives.

Negative Factors

Negative free cash flow growth

Declining free cash flow despite profits suggests operating cash is not translating into discretionary cash for reinvestment or shareholder returns. If persistent, this limits organic expansion, forces external financing, and raises funding risk for longer-term capacity projects and modernization.

Negative EPS growth

A contraction in EPS indicates that per-share earnings are under pressure despite revenue growth. Continued EPS declines would impair return on equity and may constrain internal capital allocation, weakening the firm's ability to fund expansion or increase shareholder distributions sustainably.

Cash conversion gap between profit and free cash

The gap between healthy operating cash flow and weak free cash flow points to capex intensity or working capital drag common in hospital expansion. Structurally higher cash conversion risk can limit liquidity, increase reliance on debt, and slow the pace of durable network investment if not resolved.

Jupiter Life Line Hospitals Ltd. Business Overview & Revenue Model

Company Description

Jupiter Life Line Hospitals Ltd. (JLHL) is a healthcare organization based in India that operates a network of multi-specialty hospitals, providing comprehensive medical services across various sectors including cardiology, oncology, neurology, orthopedics, and critical care. The company is dedicated to delivering high-quality healthcare solutions through advanced medical technology and expert clinical staff, focusing on patient-centric care and innovative treatment options.

How the Company Makes Money

Jupiter Life Line Hospitals Ltd. generates revenue primarily through patient admissions, which includes inpatient and outpatient services. The hospital charges fees for consultations, diagnostic tests, surgical procedures, and various therapeutic treatments. Additionally, JLHL may earn income from health insurance partnerships, where they receive reimbursements for services provided to insured patients. The company might also generate revenue from ancillary services, such as pharmacy, laboratory, and radiology services offered within their facilities. Strategic partnerships with insurance providers and corporate health programs contribute significantly to their earnings, as these collaborations often lead to increased patient volume and consistent revenue streams.

Jupiter Life Line Hospitals Ltd. Financial Statement Overview

Summary

Jupiter Life Line Hospitals Ltd. demonstrates strong financial health with consistent revenue and profit growth. The balance sheet is stable with manageable leverage, but cash flow management requires attention due to negative free cash flow growth.

Income Statement

Jupiter Life Line Hospitals Ltd. has shown consistent revenue growth over the years, with a notable increase in gross profit margins, indicating efficient cost management. The net profit margin has improved, reflecting enhanced profitability. EBIT and EBITDA margins are strong, showcasing operational efficiency.

Balance Sheet

The company has a healthy debt-to-equity ratio, indicating a balanced approach to leveraging. The return on equity is robust, suggesting effective use of shareholder funds. The equity ratio is stable, reflecting a solid financial foundation.

Cash Flow

While operating cash flow is strong, the negative free cash flow growth and ratio to net income indicate potential challenges in cash management. The operating cash flow to net income ratio is healthy, but improvements in free cash flow are needed.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	13.22B	12.62B	10.70B	8.93B	7.33B	4.86B
Gross Profit	10.74B	10.31B	8.55B	7.11B	4.07B	2.41B
EBITDA	3.44B	3.25B	2.61B	2.06B	1.50B	637.55M
Net Income	1.92B	1.93B	1.77B	729.05M	511.28M	-22.97M
Balance Sheet
Total Assets	0.00	19.05B	12.81B	9.86B	9.09B	7.89B
Cash, Cash Equivalents and Short-Term Investments	6.03B	6.03B	3.18B	1.36B	1.06B	266.46M
Total Debt	0.00	3.93B	623.41M	4.69B	4.95B	4.26B
Total Liabilities	-13.56B	5.49B	1.13B	6.22B	6.20B	5.42B
Stockholders Equity	13.56B	13.56B	11.69B	3.66B	2.94B	2.39B
Cash Flow
Free Cash Flow	0.00	-674.22M	292.26M	399.24M	452.40M	-1.18B
Operating Cash Flow	0.00	2.53B	1.15B	1.17B	1.37B	1.23B
Investing Cash Flow	0.00	-2.09B	-758.89M	-1.04B	-852.46M	-2.96B
Financing Cash Flow	0.00	3.01B	1.28B	175.00M	322.02M	1.84B

Jupiter Life Line Hospitals Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1542.60
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JLHL, the sentiment is Negative. The current price of 1542.6 is above the 20-day moving average (MA) of 1336.26, above the 50-day MA of 1386.32, and above the 200-day MA of 1451.09, indicating a bearish trend. The MACD of -26.99 indicates Positive momentum. The RSI at 34.19 is Neutral, neither overbought nor oversold. The STOCH value of 22.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JLHL.

Jupiter Life Line Hospitals Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NH	71 Outperform	₹361.28B	42.54	―	0.24%	14.72%	8.37%
JLHL	67 Neutral	₹88.23B	46.78	―	0.14%	18.40%	7.30%
KIMS	65 Neutral	₹241.54B	70.69	―	―	25.74%	1.41%
MEDANTA	65 Neutral	₹283.59B	50.46	―	0.04%	15.78%	15.01%
ASTERDM	62 Neutral	₹286.68B	86.44	―	0.84%	-36.14%	-93.99%
FORTIS	61 Neutral	₹642.96B	63.41	―	0.11%	15.33%	54.62%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Jupiter Life Line Hospitals Ltd. Corporate Events

Jupiter Life Line Hospitals Publishes Q3 and Nine-Month FY2025 Unaudited Results

Jupiter Life Line Hospitals Ltd. has published its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, following approval by its board on January 30, 2026. The company reported growth in operational income, with consolidated revenue from operations reaching ₹3,744.96 million for the quarter and ₹11,451.68 million for the nine-month period, alongside steady profitability reflected in net profit and earnings per share metrics. The results were released via newspaper advertisements in Financial Express and the Marathi daily Pudhari and are also available on the company’s website, underscoring its compliance with SEBI’s disclosure norms and providing investors and other stakeholders with updated visibility into its financial performance for the current fiscal year.

Jupiter Life Line Hospitals Announces Unaudited Financial Results for Q2 2025

Jupiter Life Line Hospitals Ltd. has announced the publication of its unaudited financial results for the quarter and half year ended September 30, 2025. The results, approved by the Board of Directors, have been published in Financial Express and Pudhari Newspaper Marathi and are available on the company’s website. This announcement reflects the company’s commitment to transparency and regulatory compliance, potentially impacting its stakeholders by providing insights into its financial performance.